Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo
John T. Heap, Jan Theys, Muhammad Ehsaan, Aleksandra M. Kubiak, Ludwig Dubois, Kim Paesmans, Lieve Van Mellaert, Richard Knox, Sarah A. Kuehne, Phillipe Lambin, Nigel P. Minton*
Research output: Contribution to journal › Article › Academic › peer-review
55Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo'. Together they form a unique fingerprint.